HOME >> BIOLOGY >> NEWS
Rett Syndrome traced to defective gene 'silencer'

September 30, 1999-- A 14-year search for the cause of a rare genetic disease that strikes young girls has uncovered the first example of a human disease linked to a defect in a mechanism designed to keep certain genes silent. This discovery may provide new insights into nervous system development in the fetus and young child.

Rett syndrome (RTT) is a neurodevelopmental disorder seen in young girls that causes a sudden and permanent decline in mental capabilities. In 1985, HHMI investigator Huda Zoghbi, who was then a neurology fellow, published a clinical research report on Rett syndrome. Her initial encounter with the disorder had a lasting impact on her career. Shortly after seeing her first RTT patients, Zoghbi decided to change her career plans, switching from clinical medicine to a research position. Shortly after switching to research, she started the long, tedious search for the genetic causes of RTT.

"Finding that gene is the hardest thing I've ever worked on," Zoghbi said in an interview. "It's the best case for the rewards of perseverance that I can think of."

The gene, called MECP2, resides on the far end of the longest arm of the X chromosome. MECP2 encodes a protein named methyl-CpG-binding protein 2, or MeCP2, that binds to genes that a cell has methylated. During development certain genes that are to be silenced, or prevented from being expressed, are physically marked by the addition of methyl groups. When bound to a methylated gene, MeCP2 facilitates gene silencing by attracting other proteins that prevent access to the cell's DNA transcription machinery.

Previous work by other researchers had shown that inactivating the mouse version of Mecp2 caused a lethal defect in male mouse embryos. Zoghbi's group at Baylor College of Medicine, in collaboration with researchers led by

Contact: Jim Keeley
keeleyj@hhmi.org
301-215-8858
Howard Hughes Medical Institute
1-Oct-1999


Page: 1 2 3 4

Related biology news :

1. Introduction of the Rett protein in post-mitotic neurons rescues Rett Syndrome in mice
2. Researchers discover novel form of the Rett Syndrome protein
3. Study offers new insight into Rett Syndrome
4. RSRF-funded study leads to breakthrough for Rett Syndrome research
5. The Rett Syndrome Research Foundation commits $1.3 million for 2003 research awards
6. Folic acid may have no immediate impact on Down Syndrome
7. A derivative of the green tea leaf may help with Metabolic Syndrome X, a potentially deadly disorder
8. Researchers find a genetic connection in Sudden Infant Death Syndrome (SIDS)
9. CDC MMWR: Fetal Alcohol Syndrome and Cutaneous Anthrax in a Lab Worker
10. Scientists create first animal model of Rett Syndrome
11. Gene for DiGeorge Syndrome discovered

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/15/2019)... ... August 15, 2019 , ... Deep Science Ventures ... Food and Agriculture practice, a new unit dedicated to building 100 companies over the ... raw materials and supply chains. , Deep Science Ventures was founded to create ...
(Date:8/14/2019)... ... ... Join Jonathan Riek, PhD, VP, Musculoskeletal & Metabolic Imaging, BioTel Research ... EDT to learn about two common imaging methods in NAFLD/NASH to aid with early ... diffuse liver disease, with a worldwide prevalence of 20-46 percent. NAFLD can be subdivided ...
(Date:8/9/2019)... ... , ... With a demand in healthcare to lower unneeded emergency room visits ... centers (UCC) in the coming years, according to a new report on the industry ... Centers , is a detailed look at the current state of these healthcare outlets, ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... , ... June 10, 2019 , ... ... and technology in an upcoming episode, scheduled to broadcast 4Q/2019. Check your local ... Group) and will educate viewers about how its technology facilitates laboratories to improve ...
(Date:6/11/2019)... Md. and ROANOKE, Va. (PRWEB) , ... June ... ... care optimized for microlearning engagement, and Carilion Clinic, a national leader in opioid ... the latest in virtual care. , Mytonomy recently deployed its virtual ...
(Date:6/11/2019)... N.C. (PRWEB) , ... June 11, 2019 , ... ... extracellular vesicles derived from human mesenchymal stem cells (MSC-EV) are able to incorporate ... cloning ability. In a test on mice, MSC-EVs also increased the cells’ ability ...
(Date:5/31/2019)... ... , ... For many years, the primary forms of cancer treatment have been ... in immuno-oncology have led to the advent of Chimeric Antigen Receptor T (CAR T) ... known as “CARs”. The CAR enables the final product to produce chemicals in the ...
Breaking Biology Technology:
Cached News: